Focus on Technological Advances in Genomics and Cellular Analysis SANTA CLARA, Calif., March 30, 2017 Agilent Technologies Inc. (NYSE: A) today announced it will showcase some of its most recent technological advances in the areas of cell analysis and genomics at the AACR Annual Meeting 2017, being held April 1 – 5, 2017 in Washington,... Read more
New Target Enrichment Product Delivers Deep Coverage of Disease Relevant Content SANTA CLARA, Calif., March 21, 2017 Agilent Technologies Inc. (NYSE: A) today introduced a new target enrichment solution for next-generation DNA sequencing. Agilent SureSelect Clinical Research Exome V2 delivers more than 1,000 additional, disease relevant targets compared to the company’s earlier version of the... Read more
Former Agilent Commercial VP Brings Deep Industry and Marketing Experience to New Role SANTA CLARA, Calif., March 20, 2017 Agilent Technologies Inc. (NYSE: A) today announced that Samraat “Sam” Raha has been named senior vice president of strategy and corporate development, reporting to Agilent President and CEO Mike McMullen. Raha will serve as strategic lead... Read more
Former Singapore Airlines Chairman Succeeds James G. Cullen, Who Will Continue to Serve as a Director SANTA CLARA, Calif.–(BUSINESS WIRE)–Mar. 15, 2017– Agilent Technologies Inc. (NYSE: A) today announced that Koh Boon Hwee has been elected chairman of the board, effective at the end of today’s shareholders’ meeting. Koh, who has been a member of... Read more
Awarded to the Agilent 1260 Infinity II LC System SANTA CLARA, Calif., March 9, 2017 Agilent Technologies Inc. (NYSE: A) has received a 2017 Scientists’ Choice Award for Best New Separation Product: The Agilent 1260 Infinity II LC system. The award recognizes the product that has made the most difference to chromatography as nominated by... Read more
Greater Sensitivity and Accuracy for Life Science Research and Testing SANTA CLARA, Calif., March 8, 2017 Agilent Technologies Inc. (NYSE: A) today expanded its portfolio of scientific instruments with a new LC/MS system that provides even greater sensitivity and accuracy for applications such as peptide quantitation, food safety, environmental testing, clinical research and forensic toxicology.... Read more
New LC/Q-TOF MS System with AdvanceBio Peptide Plus Column Provide Optimization for Biopharma Research SANTA CLARA, Calif., March 7, 2017 Agilent Technologies Inc. (NYSE: A) introduces the latest addition to its portfolio of solutions for biopharmaceutical labs: the Agilent 6545XT AdvanceBio LC/Q-TOF MS System. Optimized to address analytical workflows commonly used in biopharma, the new... Read more
GenetiSure Dx Postnatal Assay Can Help Move Inquiries from Cause to Care Faster SANTA CLARA, Calif., March 2, 2017 Agilent Technologies Inc. (NYSE: A) has introduced its first comparative genomic hybridization (CGH) assay for diagnostic use: the GenetiSure Dx Postnatal Assay. This assay will enable clinical geneticists to detect genetic anomalies earlier and more accurately... Read more
Solomon honored for her leadership in developing nucleic-acid and microfluidic products SANTA CLARA, Calif., Feb. 23, 2017 Agilent Technologies Inc. (NYSE: A) today announced that Dr. Darlene Solomon, Agilent senior vice president and chief technology officer, has been elected to the National Academy of Engineering — considered among the highest professional distinctions accorded to an... Read more
SANTA CLARA, Calif.–(BUSINESS WIRE)–Feb. 23, 2017– Agilent Technologies Inc. (NYSE:A) today announced the following webcasts for the investment community. Cowen and Co. 37thAnnual Healthcare Conference WebcastWednesday, March 8, 2017 at 8:00 a.m. (ET)Boston Marriott Copley Place, Boston, MassachusettsDidier Hirsch, Agilent chief financial officerMark Doak, Agilent CrossLab Group president Agilent Technologies Annual Meeting of Shareholders WebcastWednesday,... Read more